Nelson Capital Management, LLC Biogen Inc. Transaction History

Nelson Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 09, 2019	SELL	$216.71 - $338.96 $650 - $1,016	-3 Closed	0 $0
Q3 2018 Oct 09, 2018	BUY	$293.51 - $383.83 $880 - $1,151	3 New	3 $1,000
Q1 2018 Apr 20, 2018	SELL	$260.13 - $367.91 $780 - $1,103	-3 Closed	0 $0
Q4 2017 Jan 26, 2018	BUY	$307.64 - $344.58 $922 - $1,033	3	3 $1,000

995

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Nelson Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nelson Capital Management, LLC with notifications on news.